[1] |
Chang HC, Wang TJ, Lin MH, et al. A review of the systemic treatment of Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Biomedicines, 2022,10(9):2105. doi: 10.3390/biomedicines10092105.
|
[2] |
Chung WH, Wang CW, Dao RL. Severe cutaneous adverse drug reactions[J]. J Dermatol, 2016,43(7):758⁃766. doi: 10.1111/1346⁃8138.13430.
|
[3] |
Gibson A, Deshpande P, Campbell CN, et al. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions[J]. J Allergy Clin Immunol, 2023,151(2):289⁃300. doi: 10.1016/j.jaci.2022.12.005.
|
[4] |
Shao F, Gao Y, Wang W, et al. Silencing EGFR⁃upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade[J]. Nat Cancer, 2022,3(10):1192⁃1210. doi: 10.1038/s43018⁃022⁃00444⁃4.
|
[5] |
Sutavani RV, Bradley RG, Ramage JM, et al. CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype[J]. J Immunol, 2013,191(12):5895⁃5903. doi: 10.4049/jimmunol.1301458.
|
[6] |
Li L, Ding P, Lv X, et al. CD59⁃regulated Ras compartmentalization orchestrates antitumor T⁃cell immunity[J]. Cancer Immunol Res, 2022,10(12):1475⁃1489. doi: 10.1158/2326⁃6066.CIR⁃21⁃1072.
|
[7] |
中华医学会皮肤性病学分会药物不良反应研究中心. Stevens⁃Johnson综合征/中毒性表皮坏死松解症诊疗专家共识[J]. 中华皮肤科杂志, 2021,54(5):376⁃381. doi: 10.35541/cjd.2020 1177.
|
[8] |
Karakus M, Pantet O, Charrière M, et al. Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia[J]. Clin Nutr, 2023,42(6):859⁃868. doi: 10.1016/j.clnu.2023.04.006.
|
[9] |
Cao J, Zhang X, Xing X, et al. Biologic TNF⁃α inhibitors for Stevens⁃Johnson syndrome, toxic epidermal necrolysis, and TEN⁃SJS overlap: a study⁃level and patient⁃level meta⁃analysis[J]. Dermatol Ther (Heidelb), 2023,13(6):1305⁃1327. doi: 10.1007/s13555⁃023⁃00928⁃w.
|
[10] |
Kinoshita M, Ogawa Y, Hama N, et al. Neutrophils initiate and exacerbate Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Sci Transl Med, 2021,13(600):eaax2398. doi: 10.1126/scitranslmed.aax2398.
|
[11] |
Viard⁃Leveugle I, Gaide O, Jankovic D, et al. TNF⁃α and IFN⁃γ are potential inducers of Fas⁃mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis[J]. J Invest Dermatol, 2013,133(2):489⁃498. doi: 10.1038/jid.2012.330.
|
[12] |
Lavergne M, Hernández⁃Castañeda MA, Mantel PY, et al. Oxidative and non⁃oxidative antimicrobial activities of the granzymes[J]. Front Immunol, 2021,12:750512. doi: 10.3389/fimmu.2021.750512.
|
[13] |
Saeed HN, Chodosh J. Immunologic mediators in Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Semin Ophthalmol, 2016,31(1⁃2):85⁃90. doi: 10.3109/08820538.2015. 1115255.
|
[14] |
Tang H, Hu X, Li L, et al. Complement regulatory proteins: candidate biomarkers in differentiating tuberculosis pleural effusion[J]. Front Immunol, 2023,14:1073884. doi: 10.3389/fimmu.2023.1073884.
|
[15] |
Reis ES, Mastellos DC, Hajishengallis G, et al. New insights into the immune functions of complement[J]. Nat Rev Immunol, 2019,19(8):503⁃516. doi: 10.1038/s41577⁃019⁃0168⁃x.
|
[16] |
Bharti R, Dey G, Lin F, et al. CD55 in cancer: complementing functions in a non⁃canonical manner[J]. Cancer Lett, 2022,551:215935. doi: 10.1016/j.canlet.2022.215935.
|
[17] |
Chighizola CB, Lonati PA, Trespidi L, et al. The complement system in the pathophysiology of pregnancy and in systemic autoimmune rheumatic diseases during pregnancy[J]. Front Immunol, 2020,11:2084. doi: 10.3389/fimmu.2020.02084.
|
[18] |
Wang F, Huang L, Yu J, et al. Altered levels of complement components associated with non⁃immediate drug hypersensitivity reactions[J]. J Immunotoxicol, 2020,17(1):1⁃9. doi: 10.1080/1547691X.2019.1695985.
|
[19] |
Voisin TB, Couves EC, Tate EW, et al. Dynamics and molecular interactions of GPI⁃anchored CD59[J]. Toxins (Basel), 2023,15(7):430. doi: 10.3390/toxins15070430.
|
[20] |
Geller A, Yan J. The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy[J]. Front Immunol, 2019,10:1074. doi: 10.3389/fimmu.2019.01074.
|
[21] |
Michielsen LA, Budding K, Drop D, et al. Reduced expression of membrane complement regulatory protein CD59 on leukocytes following lung transplantation[J]. Front Immunol, 2017,8:2008. doi: 10.3389/fimmu.2017.02008.
|